Patents matching “ONC”

US 6514745

Oncoprotein protein kinase

The Regents of the University of California · Granted Feb 4, 2003 · Expires Jan 30, 2023

US 6455038

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Sep 24, 2002 · Expires Sep 19, 2022

US 6451759

Noncleavable Fas ligand

The Regents of the University of California · Granted Sep 17, 2002 · Expires Sep 12, 2022

US 6344195

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Feb 5, 2002 · Expires Jan 31, 2022

US 6342595

Oncoprotein protein kinase

The Regents of the University of California · Granted Jan 29, 2002 · Expires Jan 24, 2022

US 6261555

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6193965

Oncoprotein kinase

The Regents of the University of California · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6136307

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Oct 24, 2000 · Expires Oct 19, 2020

US 6110461

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Aug 29, 2000 · Expires Aug 24, 2020

US 6074653

Cosmetic/dermatological w/o emulsions highly concentrated in hydroxy acids

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Jun 13, 2000 · Expires Jun 8, 2020